Slide 1: Third Quarter 2025 Earnings
Click Here to Edit Title Third Quarter 2025 Earnings October 29, 2025
Slide 2: Cautionary Statement
Cautionary Click Here to Statement Edit Title Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements ma
Slide 3: The Purposeful Evolution of IDEX
The Purposeful Evolution of IDEX $3.3B 2 0 2 4 R E V E N U E S PHASE III PILLARS O F HIGHER GROW TH WITH 8020 PHASE II Targeting higher-growth, 1 OPTIMIZED WITH 8020 advantaged markets Introduced 8020, accelerated talent development, applied shared PHASE I operating approach and enhanced Acceleratin
Slide 4: Targeting Higher-Growth, Advantaged Markets
1 Targeting Higher-Growth, Advantaged Markets 8020 Focus: Upgrade portfolio vitality through proprietary M&A and selective divesture Data Centers Space and Defense Semiconductor Water • Airtech and Muon • Iridian, STC, Muon, Mott, • Muon and Mott • Nexsight and Subterra • Thermal management Micro-La
Slide 5: Commercial and Operational Business Integration
2 Commercial and Operational Business Integration 8020 Focus: Integrate technologies and market access points within growth platforms Materials Science Solutions Muon Update Our 8020 Focus: • Improving operational productivity MATERIALS • Streamlining cost structure Form critical properties • Focusi
Slide 6: Balanced Capital Deployment
3 Balanced Capital Deployment 8020 Focus: Near-term, target bolt-on acquisitions and return capital to shareholders Framework for Capital Allocation Near-Term Deployment Highlights Target 2025 Free Cash Flow Deployment 8020 Approach to Allocating FCF to M&A Return of Capital Highest Return Opportuni
Slide 7: IDEX 3Q25 Highlights
IDEX Click Here 3Q25toHighlights Edit Title Delivered better than expected results despite macro uncertainty; leveraging 8020, integrated growth strategies gaining traction Industrial businesses tracking in line with 2H expectations but leading indicator businesses showed no signs of positive inflec
Slide 8: Q3 2025 Financial Performance
Q3 Click 2025 Here Financial to Edit Title Performance ($ in millions excl. EPS) Sales Adj. EBITDA Margin* Adj. EPS* Free Cash Flow* +5% Organic* +40 bps +7% -2% Organic* FX M&A Y/Y ∆ Sales Growth 5% 1% 4% 10% Organic* orders increased 7% y/y Q3 results above expectations and reflect record order in
Slide 9: Q3 2025: Health Science Technologies
Q3 Click 2025: HereHealth to Edit& ($ in millions) Title Science Technologies 3Q25 Highlights Orders Sales Adj. EBITDA Margin • Y/Y organic orders and sales growth driven by pricing, strength in advantaged +5% Organic* +10% Organic* +120 bps markets and easier year-over-year comparisons • HST contin
Slide 10: Q3 2025: Fluid & Metering Technologies
Q3 Click 2025: HereFluid to Edit ($ in millions) & Title Metering Technologies 3Q25 Highlights Orders Sales Adj. EBITDA Margin • Orders grew on strength in municipal +8% Organic* +4% Organic* +90 bps water and project timing and easier year-over-year comparisons • Organic sales increased on price be
Slide 11: Q3 2025: Fire & Safety / Diversified Products
Q3 Click 2025: HereFire to Edit ($ in millions) & Safety Title / Diversified Products Orders 3Q25 Highlights Sales Adj. EBITDA Margin • Orders increased given easier year- +7% Organic* -5% Organic* -200 bps over-year comparisons • Sales pressured by government funding disruptions and sluggish equipm
Slide 12: Capital Deployment
Capital Deployment 8020 Focus: Near-term, return capital to shareholders and target bolt-on acquisitions 1 Capital Return Including Buybacks 2 Bolt-on Acquisitions $140 $129 $120 • Continue to return $104 capital through $102 $100 dividends and share $75 repurchases $50 $80 $50 • Increased share • S
Slide 13: 2025 Guidance Summary
2025 Click Here Guidance to EditSummary Title Full Year Full Year Current Guidance Prior Guidance Organic Revenue % vs Prior Year* No change ~1% Adjusted EBITDA %* No change 26.5% – 27.0% Reported Earnings Per Share $6.35 - $6.40 $6.30 - $6.44 Adjusted Earnings Per Share* $7.86 - $7.91 (narrowed) $7
Slide 14: IDEX Value Drivers
IDEX Value Drivers Differentiated 8020 operating model drives full business potential through simplification, focused resourcing and streamlined execution Focused on continuously evolving our portfolio toward high-growth, advantaged markets with secular tailwinds Balanced allocator of capital with s
Slide 15: Non-GAAP Reconciliations
Click Here to Edit Title Non-GAAP Reconciliations
Slide 16: Table 1: Reconciliations of the Change in Net Sales to Organic Sales
Table 1: Reconciliations of the Change in Net Sales to Organic Sales HST FMT FSDP IDEX Three Months Ended September 30, 2025 Change in net sales 22% 5% (3%) 10% Less: Net impact from acquisitions/divestitures(1) 11% —% —% 4% Impact from foreign currency(2) 1% 1% 2% 1% Change in organic net sales 10%
Slide 17: Table 3: Reconciliations of Reported-to-Adjusted Net Income
Table 3: Reconciliations of Reported-to-Adjusted Net Income Attributable to IDEX and Diluted EPS Attributable to IDEX (in millions, except per share amounts) Three Months Ended Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Reported net income attributable to IDEX $ 127.8 $ 119.1
Slide 18: Table 4: Reconciliations of Net Income to Adjusted EBITDA
Table 4: Reconciliations of Net Income to Adjusted EBITDA (dollars in millions) Three Months Ended Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Reported net income $ 127.7 $ 118.9 $ 354.2 $ 381.4 Provision for income taxes 42.8 35.5 110.7 106.7 Interest expense - net 16.5 10.3 4
Slide 19: Table 5: Reconciliations of Cash Flows to Free Cash Flow
Table 5: Reconciliations of Cash Flows from Operating Activities to Free Cash Flow (dollars in millions) Three Months Ended Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Cash flows from operating activities $ 203.5 $ 205.3 $ 470.9 $ 495.5 Less: Capital expenditures 14.8 13.7 43.9
Slide 20: Table 8: Reconciliation of Estimated 2025 Net Income to Adjusted EBITDA
Table 8: Reconciliation of Estimated 2025 Net Income to Adjusted EBITDA (dollars in millions) Guidance(4) Full Year 2025 Low End High End Estimated Reported net income $ 478.0 $ 481.6 Provision for income taxes 150.7 152.0 Interest expense - net 65.4 65.4 Depreciation 76.7 76.7 Amortization of intan